Develop a company-level strategy that outlines an internal approach to adopt Patient Technologies for specific technology types, therapeutic areas, or teams/functions, with defined program goals.
The considerations listed here are intended to help identify risks and unknowns, plus provide a list of internal stakeholders typically able to offer insight or expertise. Please note, the provided list of considerations is not all-encompassing.
As internal department names vary greatly from one company to the next, some of the listed stakeholders may not be self-explanatory. Below, you will find a short description of the more ambiguous groups:
|Clinical Technologies ||SMEs for clinical technologies, vendor relations and vendor management, technology scouting, implementation strategies as well as implementation leadership and guidance.
|Medical ||Medical or clinical SMEs for given indications and/or therapeutic areas.
|Patient Engagement ||SMEs or groups assisting with patient advisory boards, patient engagement and retention strategies, patient centricity assessments and/or patient centric strategies.
|Quality ||SMEs for qualification, testing and validation activities, processes, (vendor) audits, documentation and GxP compliance.
Other, more universally understood, stakeholders referenced include Data Management, Functional Leadership, Human Resources, IT, Legal, Procurement, Regulatory Affairs, Site Relations, and Study Teams.